PP
Prashant Paleja
About Prashant Paleja
Data last updated:
Prashant Paleja was a Director at Avenir Lifecare Pharma Private Limited (2024–2025), Director at Novacare Healthcare Solutions Private Limited (2023–2025) and Director at Western Healthcare Solutions Private Limited (2023–2025), and held 4 more directorships. The companies operate in Healthcare and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2024 | 2023 | ₹55.34 Cr (FY 2025) | Active | |
| Director | 11 Aug 2023 | 2018 | ₹527 Cr (FY 2025) | Active | |
| Director | 14 Aug 2023 | 2021 | ₹156 Cr (FY 2025) | Active | |
| Director | 20 Mar 2023 | 2022 | ₹130 Cr (FY 2025) | Active | |
| Director | 16 Aug 2023 | 2021 | Strike Off | ||
| Director | 16 Aug 2023 | 2020 | Strike Off | ||
| Director | 16 Aug 2023 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prashant Paleja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prashant Paleja
Prashant Paleja was first appointed on 20 Mar 2023 as Director at S.S. Pharma Traders Private Limited. The most recent appointment on record is 01 Jul 2024 at Avenir Lifecare Pharma Private Limited.
Prashant Paleja held 7 earlier board appointments: Avenir Lifecare Pharma Private Limited (Director, 01 Jul 2024 to 07 Oct 2025); Novacare Healthcare Solutions Private Limited (Director, 11 Aug 2023 to 07 Oct 2025); Western Healthcare Solutions Private Limited (Director, 14 Aug 2023 to 07 Oct 2025); S.S. Pharma Traders Private Limited (Director, 20 Mar 2023 to 07 Oct 2025); Zennx Software Solutions Private Limited (Director, from 16 Aug 2023); and 2 more.